Induction therapy with rabbit antithymocyte globulin versus basiliximab after kidney transplantation: a health economic analysis from a German perspective-Reference-Cited by-同舟云学术

Induction therapy with rabbit antithymocyte globulin versus basiliximab after kidney transplantation: a health economic analysis from a German perspective

Published:2017-07-24 Issue:10 Volume:30 Page:1011-1019
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Cremaschi Liana¹,von Versen Regina²,Benzing Thomas²,Wiesener Michael³,Zink Nikolai³,Milkovich Gary⁴,Paivanas Thomas⁴,Gallagher Meghan⁵,Thaiss Friedrich¹^ORCID

Affiliation:

1. Department of Nephrology; University Hospital Eppendorf UKE; Hamburg Germany

2. Nephrology, Rheumatology, Diabetology and General Internal Medicine; University Hospital Cologne; Cologne Germany

3. Department of Nephrology and Hypertension; University Hospital Erlangen; Erlangen Germany

4. RJM Group; LLC; Washington DC USA

5. Global Health Economics & Outcomes Research; Sanofi-Aventis US; Cambridge MA USA

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12991/fullpdf

Reference27 articles.

1. United States Renal Data System Annual Report 2014 http://www.usrds.org/2014/view/

2. New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunity;Mohty;Drugs,2014

3. Randomised trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB 201 International Study Group;Nashan;Lancet,1997

4. Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody. United States Simulect Renal Study Group;Kahan;Transplantation,1999

5. Immunoprophylaxis with basiliximab compared with antithymocyte globulin in renal transplant patients receiving MMF-containing triple therapy;Lebranchu;Am J Transplant,2002

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of lymphocyte-depleting antibodies in specific populations of kidney transplant recipients: A systematic review and meta-analysis;Transplantation Reviews;2023-12

2. Evidence of Interleukin-2-Receptor-Antibody Induction in Low-Risk Living Donor Kidney Transplantation: A Single-Center Pilot Study;Transplantation Proceedings;2020-04

3. Immunosuppression;Nephrology Self-Assessment Program;2019-11

4. The use of induction therapy in liver transplantation is highly variable and is associated with posttransplant outcomes;American Journal of Transplantation;2019-07-17

5. Low Total Dose of Anti-Human T-Lymphocyte Globulin (ATG) Guarantees a Good Glomerular Filtration Rate after Liver Transplant in Recipients with Pretransplant Renal Dysfunction;Canadian Journal of Gastroenterology and Hepatology;2018-08-16